The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Lineage Cell Therapeutics, Inc(NYSE MKT:LCTX) 
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company's lead product candidates include OpRegen, a retinal pigment epithelium cell r...
Website: http://www.lineagecell.com
Full Time Employees: 50
CEO: Brian M. Culley
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Lineage Cell Therapeutics Days Payable Outstanding ttm (DPO)
Lineage Cell Therapeutics Days Receivable Outstanding ttm (DSO)
Lineage Cell Therapeutics Op Cashflow Per Share ttm
Lineage Cell Therapeutics Free Cashflow Per Share ttm
Lineage Cell Therapeutics Cash Per Share ttm
Lineage Cell Therapeutics P/S ratio ttm
Lineage Cell Therapeutics (GAAP) P/E ratio ttm
Lineage Cell Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.